Authors:
Plumb, JA
Bilsland, A
Kakani, R
Zhao, JQ
Glasspool, RM
Knox, RJ
Evans, TRJ
Keith, WN
Citation: Ja. Plumb et al., Telomerase-specific suicide gene therapy vectors expressing bacterial nitroreductase sensitize human cancer cells to the pro-drug CB1954, ONCOGENE, 20(53), 2001, pp. 7797-7803
Authors:
Mackay, HJ
McInnes, A
Paul, J
Raby, N
Lofts, FJ
McDonald, AC
Soukop, M
Fullarton, GM
Harris, AL
Garcia-Vargas, J
Evans, TRJ
Citation: Hj. Mackay et al., A phase II study of epirubicin, cisplatin and raltitrexed combination chemotherapy (ECT) in patients with advanced oesophageal and gastric adenocarcinoma, ANN ONCOL, 12(10), 2001, pp. 1407-1410
Authors:
de Bono, JS
Dalgleish, AG
Carmichael, J
Diffley, J
Lofts, FJ
Fyffe, D
Ellard, S
Gordon, RJ
Brindley, CJ
Evans, TRJ
Citation: Js. De Bono et al., Phase I study of ONO-4007, a synthetic analogue of the lipid a moiety of bacterial lipopolysaccharide, CLIN CANC R, 6(2), 2000, pp. 397-405
Citation: Da. Anthoney et al., Inflammatory demyelinating polyneuropathy: A complication of immunotherapyin malignant melanoma, ANN ONCOL, 11(9), 2000, pp. 1197-1200
Authors:
Eatock, MM
Anthony, DA
El-Abassi, M
Wilson, P
Paul, J
Smith, M
Soukop, M
Evans, TRJ
Citation: Mm. Eatock et al., A dose-finding study of raltitrexed (tomudex) with cisplatin and epirubicin in advanced gastro-oesophageal adenocarcinoma, BR J CANC, 82(12), 2000, pp. 1925-1931
Citation: Jp. Armand et al., Raltitrexed (Tomudex (TM)) in combination with platinum-based agents and/or anthracyclines: Preliminary results of phase I clinical trials, EUR J CANC, 35, 1999, pp. S14-S18
Citation: Vj. O'Neill et al., A retrospective analysis of Hickman line-associated complications in patients with solid tumours undergoing infusional chemotherapy, ACTA ONCOL, 38(8), 1999, pp. 1103-1107